These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 32103715

  • 1. Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia Selectivity.
    Buravchenko GI, Scherbakov AM, Korlukov AА, Dorovatovskii PV, Shchekotikhin AE.
    Curr Org Synth; 2020; 17(1):29-39. PubMed ID: 32103715
    [Abstract] [Full Text] [Related]

  • 2. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
    Buravchenko GI, Scherbakov AM, Dezhenkova LG, Bykov EE, Solovieva SE, Korlukov AA, Sorokin DV, Monzote Fidalgo L, Shchekotikhin AE.
    Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
    [Abstract] [Full Text] [Related]

  • 3. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
    Vieites M, Noblía P, Torre MH, Cerecetto H, Laura Lavaggi M, Costa-Filho AJ, Azqueta A, de Cerain AL, Monge A, Parajón-Costa B, González M, Gambino D.
    J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of 7-amino-6-halogeno-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: a way forward for targeting hypoxia and drug resistance of cancer cells.
    Buravchenko GI, Scherbakov AM, Dezhenkova LG, Monzote L, Shchekotikhin AE.
    RSC Adv; 2021 Nov 29; 11(61):38782-38795. PubMed ID: 35493230
    [Abstract] [Full Text] [Related]

  • 5. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
    Amin KM, Ismail MM, Noaman E, Soliman DH, Ammar YA.
    Bioorg Med Chem; 2006 Oct 15; 14(20):6917-23. PubMed ID: 16843668
    [Abstract] [Full Text] [Related]

  • 6. Novel Quinoxaline-2-Carbonitrile-1,4-Dioxide Derivatives Suppress HIF1α Activity and Circumvent MDR in Cancer Cells.
    Scherbakov AM, Borunov AM, Buravchenko GI, Andreeva OE, Kudryavtsev IA, Dezhenkova LG, Shchekotikhin AE.
    Cancer Invest; 2018 Mar 16; 36(3):199-209. PubMed ID: 29624460
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives as hypoxic selective anti-tumor agents.
    Hu Y, Xia Q, Shangguan S, Liu X, Hu Y, Sheng R.
    Molecules; 2012 Aug 13; 17(8):9683-96. PubMed ID: 22890172
    [Abstract] [Full Text] [Related]

  • 8. [Structure-activity relationships applied to quinoxaline-1,4-dioxides].
    Schönfelder D, Stumm G, Bohle M, Niclas HJ.
    Pharmazie; 1988 Dec 13; 43(12):837-9. PubMed ID: 3073394
    [Abstract] [Full Text] [Related]

  • 9. New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.
    Urquiola C, Gambino D, Cabrera M, Lavaggi ML, Cerecetto H, González M, de Cerain AL, Monge A, Costa-Filho AJ, Torre MH.
    J Inorg Biochem; 2008 Jan 13; 102(1):119-26. PubMed ID: 17804074
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
    Monge A, Palop JA, López de Ceráin A, Senador V, Martínez-Crespo FJ, Sainz Y, Narro S, García E, de Miguel C, González M.
    J Med Chem; 1995 May 12; 38(10):1786-92. PubMed ID: 7752202
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
    Hay MP, Gamage SA, Kovacs MS, Pruijn FB, Anderson RF, Patterson AV, Wilson WR, Brown JM, Denny WA.
    J Med Chem; 2003 Jan 02; 46(1):169-82. PubMed ID: 12502371
    [Abstract] [Full Text] [Related]

  • 12. Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase.
    Abbas HA, Al-Marhabi AR, Eissa SI, Ammar YA.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6560-72. PubMed ID: 26420384
    [Abstract] [Full Text] [Related]

  • 13. Oxidative Stress Modulation and Radiosensitizing Effect of Quinoxaline-1,4-Dioxides Derivatives.
    Silva L, Coelho P, Teixeira D, Monteiro A, Pinto G, Soares R, Prudêncio C, Vieira M.
    Anticancer Agents Med Chem; 2020 Oct 15; 20(1):111-120. PubMed ID: 31746309
    [Abstract] [Full Text] [Related]

  • 14. Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs.
    Gali-Muhtasib HU, Haddadin MJ, Rahhal DN, Younes IH.
    Oncol Rep; 2001 Oct 15; 8(3):679-84. PubMed ID: 11295102
    [Abstract] [Full Text] [Related]

  • 15. Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study.
    Rivera G, Andrade-Ochoa S, Romero MSO, Palos I, Monge A, Sanchez-Torres LE.
    Anticancer Agents Med Chem; 2017 Oct 15; 17(5):682-691. PubMed ID: 27396382
    [Abstract] [Full Text] [Related]

  • 16. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
    Ortega MA, Sainz Y, Montoya ME, Jaso A, Zarranz B, Aldana I, Monge A.
    Arzneimittelforschung; 2002 Oct 15; 52(2):113-9. PubMed ID: 11878199
    [Abstract] [Full Text] [Related]

  • 17. A new efficient route for the formation of quinoxaline N-oxides and N,N'-dioxides using HOF.CH3CN.
    Carmeli M, Rozen S.
    J Org Chem; 2006 Jul 21; 71(15):5761-5. PubMed ID: 16839160
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.
    Solano B, Junnotula V, Marín A, Villar R, Burguete A, Vicente E, Pérez-Silanes S, Aldana I, Monge A, Dutta S, Sarkar U, Gates KS.
    J Med Chem; 2007 Nov 01; 50(22):5485-92. PubMed ID: 17910426
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives.
    Zarranz B, Jaso A, Aldana I, Monge A, Maurel S, Deharo E, Jullian V, Sauvain M.
    Arzneimittelforschung; 2005 Nov 01; 55(12):754-61. PubMed ID: 16430030
    [Abstract] [Full Text] [Related]

  • 20. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
    Sainz Y, Montoya ME, Martínez-Crespo FJ, Ortega MA, López de Ceráin A, Monge A.
    Arzneimittelforschung; 1999 Jan 01; 49(1):55-9. PubMed ID: 10028381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.